Swiss and German cancer researchers win 2024 Swiss Bridge Award
Two cancer researchers from Switzerland and Germany honored
Keystone-SDA
Select your language
Generated with artificial intelligence.
Listening: Swiss and German cancer researchers win 2024 Swiss Bridge Award
Tobias Weiss and Juliane Walz, cancer researchers from Switzerland and Germany respectively, have been honoured with the 2024 Swiss Bridge Award. Each will receive CHF250,000 ($288,000) to support their work in cancer treatment using immunotherapies.
This content was published on
2 minutes
Keystone-SDA
Deutsch
de
Zwei Krebsforschende aus der Schweiz und Deutschland ausgezeichnet
Original
This year’s Swiss Bridge Foundation cancer research prize focuses on supporting early-stage clinical trials, the foundation announced on Tuesday. These initial studies aim to test new drugs or therapies on patients with incurable cancer for the first time. In total, 36 young researchers from across Europe applied for the prize.
More
More
Swiss cancer research could ‘boost’ immunotherapy
This content was published on
Swiss researchers have made major advances in cancer immunotherapy but bringing these to patients faces challenges.
Tobias Weiss from the University Hospital Zurich has been researching a treatment for glioblastoma, the most common and aggressive form of brain tumour in adults. Weiss and his team extract immune cells from the patient’s blood and modify them to recognise and attack tumour cells, according to Swiss Bridge.
The second prize winner is Juliane Walz from the University of Tübingen in Germany. She and her team have been researching a bispecific antibody designed to bind specifically to two different proteins on different cell types, the report stated. They hope this dual action will effectively combat tumours.
Translated from German by DeepL/sp
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
Free trade remains ‘core’ Swiss value despite Trump tariffs
This content was published on
Swiss President Karin Keller-Sutter says Switzerland remains committed to free trade despite a new 31% tariff on Swiss exports to the United States.
This content was published on
The new regulation targets plants developed through new breeding technologies that don’t include transgenic genetic material.
WHO faces $1.8 billion budget shortfall amid US withdrawal
This content was published on
The 2026-2027 budget for the Geneva-based organisation has been reduced to $4.2 billion, on top of this year’s $600 million shortfall.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.